Apr 29, 2024 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the GeneDx first quarter 2024 earnings conference. (Operator Instructions) Please be advised that today's conference is being recorded.
And it is now my pleasure to introduce the commercial Chief of Staff, Sabrina Dunbar.
Sabrina Dunbar - GeneDx Holdings Corp - Chief of Staff
Thank you, operator, and thank you to everyone for joining us today. On the call, we have conference Katherine Stueland, President and Chief Executive Officer, and Kevin Feeley, Chief Financial Officer earlier today, and JBX released financial results for the first quarter ended March 31, 2024.
Before we begin please take note of our cautionary statements. We may make forward-looking statements on today's call, including about our business plans, guidance and outlook. Forward looking statements inherently involve risks and uncertainties and only reflect our view as of today, April 29, and we are under no obligation to update when discussing our results, we refer to non-GAAP measures, which exclude certain
Q1 2024 GeneDx Holdings Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot